Terms: = Bone cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Staging
13 results:
1. Identification of clinical implications and potential prognostic models of chromatin regulator mutations in multiple myeloma.
Zhang L; Zhang R; Wang J; Chen Y; Qiao C; Shi Q; Jin Y; Shen X; Li J; Chen L
Clin Epigenetics; 2022 Jul; 14(1):93. PubMed ID: 35870987
[TBL] [Abstract] [Full Text] [Related]
2. The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021.
Ascierto PA; Warner AB; Blank C; Caracò C; Demaria S; Gershenwald JE; Khushalani NI; Long GV; Luke JJ; Mehnert JM; Robert C; Rutkowski P; Tawbi HA; Osman I; Puzanov I
J Transl Med; 2022 May; 20(1):200. PubMed ID: 35538491
[TBL] [Abstract] [Full Text] [Related]
3. bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials.
Danziger SA; McConnell M; Gockley J; Young MH; Rosenthal A; Schmitz F; Reiss DJ; Farmer P; Alapat DV; Singh A; Ashby C; Bauer M; Ren Y; Smith K; Couto SS; van Rhee F; Davies F; Zangari M; Petty N; Orlowski RZ; Dhodapkar MV; Copeland WB; Fox B; Hoering A; Fitch A; Newhall K; Barlogie B; Trotter MWB; Hershberg RM; Walker BA; Dervan AP; Ratushny AV; Morgan GJ
PLoS Med; 2020 Nov; 17(11):e1003323. PubMed ID: 33147277
[TBL] [Abstract] [Full Text] [Related]
4. [Isolated plasmablastic lymphoma of nasal mucosa in an immunocompetent patient achieving complete remission after multimodal treatment: about an African patient and literature review].
Tissir R; Rais H; Tazi I
Pan Afr Med J; 2020; 37():22. PubMed ID: 33062124
[TBL] [Abstract] [Full Text] [Related]
5. Olfactory Neuroblastoma.
Veyrat M; Vérillaud B; Fiaux-Camous D; Froelich S; Bresson D; Nicolai P; Herman P
Adv Otorhinolaryngol; 2020; 84():154-167. PubMed ID: 32731231
[TBL] [Abstract] [Full Text] [Related]
6. Long-Term Prognostic Analysis after Endoscopic Endonasal Surgery for Olfactory Neuroblastoma: A Retrospective Study of 13 Cases.
Zhang L; Niu K; Zhu K; Xia C; Yan J; Zhao W; Wei J; Duan M; Zheng G
PLoS One; 2016; 11(11):e0166046. PubMed ID: 27806104
[TBL] [Abstract] [Full Text] [Related]
7. Carbidopa-assisted
Helali M; Addeo P; Heimburger C; Detour J; Goichot B; Bachellier P; Namer IJ; Taïeb D; Imperiale A
Ann Nucl Med; 2016 Nov; 30(9):659-668. PubMed ID: 27485404
[TBL] [Abstract] [Full Text] [Related]
8. FOXP3 and ctla4 overexpression in multiple myeloma bone marrow as a sign of accumulation of CD4(+) T regulatory cells.
Braga WM; da Silva BR; de Carvalho AC; Maekawa YH; Bortoluzzo AB; Rizzatti EG; Atanackovic D; Colleoni GW
Cancer Immunol Immunother; 2014 Nov; 63(11):1189-97. PubMed ID: 25099367
[TBL] [Abstract] [Full Text] [Related]
9. Sirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplant.
Ceberio I; Devlin SM; Sauter C; Barker JN; Castro-Malaspina H; Giralt S; Ponce DM; Lechner L; Maloy MA; Goldberg JD; Perales MA
Leuk Lymphoma; 2015 Mar; 56(3):663-70. PubMed ID: 24913499
[TBL] [Abstract] [Full Text] [Related]
10. New-onset mediastinal and central nervous system sarcoidosis in a patient with metastatic melanoma undergoing ctla4 monoclonal antibody treatment.
Murphy KP; Kennedy MP; Barry JE; O'Regan KN; Power DG
Oncol Res Treat; 2014; 37(6):351-3. PubMed ID: 24903767
[TBL] [Abstract] [Full Text] [Related]
11. staging for CLL-type non-Hodgkin's lymphoma reveals a gastrointestinal stromal tumour.
Herbers AH; Keuning JJ
Neth J Med; 2005 Feb; 63(2):74-5. PubMed ID: 15766012
[TBL] [Abstract] [Full Text] [Related]
12. Coeliac disease and (extra)intestinal T-cell lymphomas: definition, diagnosis and treatment.
Meijer JW; Mulder CJ; Goerres MG; Boot H; Schweizer JJ
Scand J Gastroenterol Suppl; 2004; (241):78-84. PubMed ID: 15696854
[TBL] [Abstract] [Full Text] [Related]
13. Pathological study of alpha-chain disease, with special emphasis on evolution.
Galian A; Lecestre MJ; Scotto J; Bognel C; Matuchansky C; Rambaud JC
Cancer; 1977 May; 39(5):2081-101. PubMed ID: 404026
[TBL] [Abstract] [Full Text] [Related]
